Le Lézard1d
Volition Proudly Sponsors the 44th ISICEM Congress
VolitionRx Limited ("Volition"), a multi-national epigenetics company, announced its participation at the 44th Annual ISICEM  ("International Symposium on Intensive Care & Emergency Medicine") ...
Hosted on MSN12d
VNRX: Additional clinical papers & company webinars provide insights to Volition’s progress. Nu.Q Discover biomarkers selected for clinical trial. Management continue…
VNRX READ THE FULL VNRX RESEARCH REPORT RECENT EVENTS Nu.Q Discover to be Utilized in a Human Clinical Study On March 4, 2025 ...
Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with a leading pharmaceutical company to utilize Volition's ...
Yahoo Finance14d
Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time
Dr. Andrew Retter, Chief Medical Officer at Volition, said: "This is a significant milestone for our Nu.Q® Discover program: the first human clinical study with a pharmaceutical company sponsor ...
The Victoria Advocate14d
Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time
Nu.Q® Discover tools provide drug developers and scientists with a range of rapid epigenetic profiling assays across pre-clinical and clinical development pathways from discovery to market ready ...
Salina Post10d
K-State students earn fall 2024 semester honors
More than 1,300 students completed degree requirements from Kansas State University in the fall 2024, while more than 4,600 ...